NO985571L - Legemiddel for autoimmunsykdommer - Google Patents

Legemiddel for autoimmunsykdommer

Info

Publication number
NO985571L
NO985571L NO985571A NO985571A NO985571L NO 985571 L NO985571 L NO 985571L NO 985571 A NO985571 A NO 985571A NO 985571 A NO985571 A NO 985571A NO 985571 L NO985571 L NO 985571L
Authority
NO
Norway
Prior art keywords
autoimmune diseases
medication
preventive
diabetes
substance
Prior art date
Application number
NO985571A
Other languages
English (en)
Other versions
NO985571D0 (no
Inventor
Toshihiko Fujiwara
Shinichi Kurakata
Takashi Fujita
Tsunemichi Hosokawa
Junichiro Fukushige
Hiroyoshi Horikoshi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO985571D0 publication Critical patent/NO985571D0/no
Publication of NO985571L publication Critical patent/NO985571L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Preventivt eller terapeutisk middel for autoimmunsykdommer bortsett fra sukkersyke av type I, som inne-holder som den aktive bestanddel et stoff som forbedrer insulinresistens.
NO985571A 1996-05-31 1998-11-27 Legemiddel for autoimmunsykdommer NO985571L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP13866796 1996-05-31
JP18185096 1996-07-11
JP31922596 1996-11-29
PCT/JP1997/001827 WO1997045141A1 (fr) 1996-05-31 1997-05-29 Remede pour maladies auto-immunes

Publications (2)

Publication Number Publication Date
NO985571D0 NO985571D0 (no) 1998-11-27
NO985571L true NO985571L (no) 1999-01-27

Family

ID=27317718

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985571A NO985571L (no) 1996-05-31 1998-11-27 Legemiddel for autoimmunsykdommer

Country Status (9)

Country Link
EP (1) EP0953355A4 (no)
KR (1) KR20000016074A (no)
CN (1) CN1226833A (no)
AU (1) AU710249B2 (no)
CZ (1) CZ388598A3 (no)
HU (1) HUP9903292A3 (no)
NO (1) NO985571L (no)
NZ (1) NZ333065A (no)
WO (1) WO1997045141A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2300813A1 (en) * 1997-08-21 1999-03-04 Hiroyuki Odaka Anti-inflammatory agent
CA2350599A1 (en) * 1998-11-20 2000-06-02 Genentech, Inc. Method of inhibiting angiogenesis
GB9913782D0 (en) * 1999-06-14 1999-08-11 Smithkline Beecham Plc Novel compounds
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
US6958355B2 (en) 2000-04-24 2005-10-25 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
AU2001294673A1 (en) * 2000-09-21 2002-04-02 Aryx Therapeutics Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis
ITFI20030058A1 (it) * 2003-03-06 2004-09-07 Univ Firenze Formulazioni farmaceutiche contenenti tiazolidinedioni
TWI418350B (zh) * 2005-06-24 2013-12-11 Sankyo Co 含有ｐｐａｒ調節劑之醫藥組成物的用途
US10512622B2 (en) 2017-07-14 2019-12-24 Cymabay Therapeutics, Inc. Treatment of intrahepatic cholestatic diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0456842T3 (da) * 1989-12-13 1996-04-15 Otsuka Pharma Co Ltd Medicinske anvendelser af M-CSF
WO1991012003A1 (en) * 1990-02-09 1991-08-22 The Upjohn Company Use of insulin sensitizing agents to treat hypertension
CA2157032C (en) * 1993-12-27 1999-09-28 Hisashi Shinkai Isoxazolidinedione derivative and use thereof
ATE210663T1 (de) * 1994-06-20 2001-12-15 Takeda Chemical Industries Ltd Kondensierte imidazolderivate, ihre herstellung und verwendung
US5594015A (en) * 1994-06-22 1997-01-14 Regents Of The University Of California Thiazolidine derivatives for the treatment of psoriasis
US5550166A (en) * 1995-03-17 1996-08-27 Ostlund; Richard E. Pinitol and derivatives thereof for the treatment of metabolic disorders
US5985275A (en) * 1995-04-12 1999-11-16 New York Blood Center β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection
EP0824583A1 (en) * 1995-05-04 1998-02-25 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
EP0953355A1 (en) 1999-11-03
CN1226833A (zh) 1999-08-25
HU9903292D0 (en) 1999-11-29
AU710249B2 (en) 1999-09-16
AU2976597A (en) 1998-01-05
HUP9903292A2 (en) 2000-07-28
HUP9903292A3 (en) 2000-08-28
NO985571D0 (no) 1998-11-27
NZ333065A (en) 2000-05-26
WO1997045141A1 (fr) 1997-12-04
KR20000016074A (ko) 2000-03-25
CZ388598A3 (cs) 1999-07-14
EP0953355A4 (en) 2002-02-27

Similar Documents

Publication Publication Date Title
DE50008336D1 (de) Mehrschichttablette zur verabreichung einer fixen kombination von tramadol und diclofenac
ES1030870Y (es) Aparato medico para el implante de un dispositivo medico, tal como un filtro sanguineo.
KR920019342A (ko) 골질환 치료제
HUP0002196A2 (hu) Gyógyhatású táplálékkiegészítő cukorbetegek részére
MXPA03007712A (es) Sales farmaceuticas.
ES2159591T3 (es) Composicion de liberacion controlada.
SG127714A1 (en) Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
NO971206D0 (no) Forlenget-frigjöringsformulering
IL133397A (en) Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
DE69531098D1 (de) Piperidine und pyrrolidine
DE59907481D1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
NO985571L (no) Legemiddel for autoimmunsykdommer
PT998287E (pt) Utilizacao de levobupivacaina
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
TR199600421A2 (tr) Florfenil ikameli alkenil karbon asit-guanidid, bunlarin imalatina mahsus usul, bunlarin ilac ya da diagnoz maddesi olarak kullanilmalari ve bunlari ihtiva eden ilaclar.
DE68900029D1 (de) Pyrazolderivate, verfahren zu ihrer herstellung und diese derivate als aktive komponente enthaltende insektizide, mitizide und fungizide zusammensetzungen.
FI884545A0 (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
CO4940457A1 (es) Composiciones farmaceuticas que comprenden sensibilizadores a insulina para tratamiento de la diabetes
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
DE69012742D1 (de) Azolderivate und fungizide Medikamente, diese als wirkende Komponente enthaltend.
ES2186909T3 (es) Agentes antipaludicos y antibabesiosis y composiciones farmaceuticas que los contienen.
NO980564D0 (no) Sulfonamid-substituerte forbindelser, fremgangsmåte for fremstilling, anvendelse som medikament eller diagnostikum samt oppnådd medikament er beskrevet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application